期刊文献+

血管内皮祖细胞与糖尿病血管病变研究进展 被引量:2

下载PDF
导出
摘要 糖尿病是由多种病因引起的以高血糖为特征的代谢异常综合征。随着病程延长,其代谢紊乱可导致大血管、微血管的慢性进行性病变,是糖尿病患者致死、致残的主要原因。血管内皮功能障碍是糖尿病血管病变的始发因素,骨髓、外周血和脐血中存在一种细胞,被称为血管内皮祖细胞(endothelial progenitorceils,EPCs),它能进一步分化为内皮细胞而参与受损血管内皮的修复与血管新生,在修复心梗患者心脏血管的病变,改善冠心病、肢体缺血、脑中风、糖尿病患者血管损伤等方面有独特的功能。
作者 柳燕 方朝晖
出处 《中医药临床杂志》 2012年第2期173-175,共3页 Clinical Journal of Traditional Chinese Medicine
基金 国家中医临床研究基地--糖尿病重点病种研究 国家自然科学基金--基于内皮祖细胞研究益气活血法治疗糖尿病血管病变的作用机制(81072780) 国家自然科学基金项目81072780 国家中医药临床研究基地--糖尿病重点研究病种 国家中医药重点学科--内分泌学科:国家中医药管理局中医药科学技术研究专项(06-07LP22) 国家科技重大专项课题--重大新药创制(2010ZX09102) 中医药行业科研专项--基于社区的糖尿病中医药干预及推广应用研究(201007004)
  • 相关文献

参考文献13

  • 1Kuki S,Imanishi T,Kobayashi K.Hyperglycemia acceleratedendot helial progenitor cell senescence via the activation of P38 mitogen-activated protein kinaseJ.CircJ,2006,70(8):1076 ~1081.
  • 2Asabara T,Murohara T,Alison S,et al.Isolation of putative progenitor endothelial progenitor endothelial cells of angiogenesis.Science,1997,275 (5302):9642967.
  • 3Rosso A,Balsamo A,Gambino R,et al.p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes.J Biol Chem,2006,281:4339 ~4347.
  • 4李建辉,初少莉,姬开达,李华.胰岛素对人脐血内皮祖细胞生物活性的影响[J].上海交通大学学报(医学版),2008,28(8):967-970. 被引量:3
  • 5付秀立,赵湜,王红祥,李竞.糖尿病周围血管病患者内皮祖细胞一氧化氮、内皮型一氧化氮合酶含量的变化[J].中国现代医学杂志,2010,20(2):251-253. 被引量:3
  • 6Vantle M.Huntgehurth M,Caglayen E,et al.P I32kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Srcfamily kinases..FEBS Lett,2006,580.(30):676926776.
  • 7Tepper OM,Galiano RD,Capla JM,et al Human endothelial progenitor cells from type 2 diabetics exhibitim paired proliferation,adhesion,and incorporation into vascular structures.Circulation,2002,106(22):2781 ~2786.
  • 8Urbich C,D immeler S.Endothelial progenitor cells:characterization and role invascular biology.Circ Res,2004,95 (4):343 ~353.
  • 9Peichev M,Naiyer AJ,Pereira D,et al.Expression of VEGFR-2 and AC133 by circulating human CD34 + cells identifies a population of functional endothelial precursors.Blood,2000,95:9522958.
  • 10Gehling UM,Ergun S,Schumacher U,et al.Invitro differentiation of endothelial cells from AC133-positive progenitor cells.Blood,2000,95:310623112.

二级参考文献47

  • 1Tu-gang CHEN Jun-zhu CHEN Xu-dong XIE.Effects of aspirin on number,activity and inducible nitric oxide synthase of endothelial progenitor cells from peripheral blood[J].Acta Pharmacologica Sinica,2006,27(4):430-436. 被引量:8
  • 2[1]Feener, EP, and King GL. Vascular dysfunction in diabetes mellitus. Lancet, 1997,350(Suppl 1): S19
  • 3[2]Abaci A, Oguzhan A, Kahraman S et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation, 1999,99: 2239
  • 4[3]De Vriese, AS, Verbeuren TJ, Van de Voorde J et al. Endothelial dysfunction in diabetes. Br J Pharmacol, 2000,130: 963
  • 5[4]Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003, 348(7): 593
  • 6[5]Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000, 97(7): 3422
  • 7[6]Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Cir Res, 2001, 89(1): E1
  • 8[7]Tepper OM, Galiano DR, Capla JM et al. Human endothelial progenitor cells from type Ⅱ diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation, 2002, 106(22): 2781
  • 9[8]Walter DH, Rittig K, Bahlmann FH et al. Statin therapy accelerate reendothelialization. Circulation, 2002, 105(25): 3017
  • 10[9]Benjamin, LE. Glucose, VEGF-A, and diabetic complications. Am J Pathol, 2001,158: 1181

共引文献31

同被引文献11

  • 1张松,饶邦复,葛均波.肿瘤坏死因子-α在病毒性心肌炎发病中的作用及意义[J].中国免疫学杂志,2005,21(4):312-314. 被引量:9
  • 2Rubier S,Dlugash J, Yuceoglu YZ, et al . New type of cardiomyopathy associated with diabetic glomerulosclerosis [J]. Am J Cardiol ,1972, 30(6)=595-602.
  • 3Mytas DZ,Stougiannos PN, Zairis MN,et al . Diabetic myocardial disease: pathophysiology. early diagnosis and thera-peutic options[J]. J Diabetes Complications , 2009, 23 (4): 273-282.
  • 4Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence,mechanisms, and treatment options[J]. J Am Coll Cardiol,2008,51:93-102.
  • 5Von Bibra H, St John Sutton M. Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis[j]. DiabetoLogia .2010, 53( 6):1033-1045.
  • 6Song GY,Wu YJ,Yang Y]. et al . The accelerated post-infarction progression of cardiac remodelling is associated with genetic changes in an untreated streptozotocin-induced diabetic rat model[j]. Eur J Heart Fail ,2009 , 11(10) :911-921.
  • 7Skundric DS, Lisak RP. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration [J]. Int J Exp Diabetes Res,2003,4(4) : 303.
  • 8章容,李素梅.内皮祖细胞在糖尿病血管病变中的作用及干预治疗[J].国际病理科学与临床杂志,2009,29(4):353-356. 被引量:7
  • 9王喜梅,吴永健.胰岛素抵抗与糖尿病心肌病的研究进展[J].中国糖尿病杂志,2010,18(3):229-231. 被引量:6
  • 10姚丽萍,熊霞.血管内皮祖细胞与血管新生的研究进展[J].西南军医,2010,12(6):1167-1169. 被引量:5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部